[ad_1] First-line therapy for gastric cancer and metastatic colorectal cancer, neoadjuvant therapy for hepatocellular carcinoma HONGKONG, Dec. 5, 2023  /PRNewswire/ — Akeso (9926.HK) published results from three investigator-initiated trials (IITs)…